Assuring Quality for Non-hospital–based Biologic Infusions in Pediatric Inflammatory Bowel Disease: A Clinical Report From the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition-Reference-Cited by-同舟云学术

Assuring Quality for Non-hospital–based Biologic Infusions in Pediatric Inflammatory Bowel Disease: A Clinical Report From the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

Published:2018-04 Issue:4 Volume:66 Page:680-686
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Barfield Elaine,Sockolow Robbyn,Hoffenberg Edward,Saeed Shehzad,Kim Sandra,Siebold Leah,Picoraro Joseph,Moses Jonathan,Dykes Dana,Grossman Andrew,Wahbeh Ghassan,Park K.T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference25 articles.

1. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends;Benchimol;Inflamm Bowel Dis,2011

2. Natural history of Crohn's disease: comparison between childhood- and adult-onset disease;Pigneur;Inflamm Bowel Dis,2010

3. Health insurance paid costs and drivers of costs for patients with Crohn's disease in the United States;Park;Am J Gastroenterol,2016

4. A home infliximab infusion program;Condino;J Pediatr Gastroenterol Nutr,2005

5. The incidence and management of infusion reactions to infliximab: a large center experience;Cheifetz;Am J Gastroenterol,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes for Standardized Home and Hospital-Based Infusions of Infliximab for Children With Inflammatory Bowel Disease;Journal of Pediatric Gastroenterology & Nutrition;2023-03-16

2. Denials, Dilly-dallying, and Despair: Navigating the Insurance Labyrinth to Obtain Medically Necessary Medications for Pediatric Inflammatory Bowel Disease Patients;Journal of Pediatric Gastroenterology & Nutrition;2022-07-15

3. Clinic- and Hospital-Based Home Care, Outpatient Parenteral Antimicrobial Therapy (OPAT) and the Evolving Clinical Responsibilities of the Pharmacist;Pharmacy;2020-12-07

4. Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost Savings in Inflammatory Bowel Diseases;American Journal of Gastroenterology;2020-07-23

5. The Argument Against a Biosimilar Switch Policy for Infliximab in Patients with Inflammatory Bowel Disease Living in Alberta;Journal of the Canadian Association of Gastroenterology;2020-01-24